HQP1351

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Chronic Myeloid Leukemia, Chronic Phase

Drug Information

Target Indication

Chronic Myeloid Leukemia, Chronic Phase

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

Related Pipeline

Higher-risk Myelodysplastic Syndrome

CLL/SLL

Relapsed/Refractory Acute Myeloid Leukaemia

GIST

CLL/SLL